Format

Send to

Choose Destination
See comment in PubMed Commons below
Hastings Cent Rep. 1998 Mar-Apr;28(2):27-41.

Last chance therapies and managed care. Pluralism, fair procedures, and legitimacy.

Author information

1
Tufts University, USA.

Abstract

How can health plans make fair determinations about when "experimental" (and costly) treatments such as high dose chemotherapy with autologous bone marrow transplantation should be covered despite lack of clear clinical consensus about their benefits? Different models for managing "last chance" therapies evolving in some health plans offer promising examples of how issues of fairness and legitimacy in decision-making can be addressed.

PMID:
9589291
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center